Biomarkers of subclinical atherosclerosis in patients with psoriasis
Abstract Psoriasis is linked with increased risk of cardiovascular disease (CVD) that is underestimated by traditional risk stratification. We conducted a large-scale plasma proteomic analysis by use of a proximity extension assay in 85 patients with a history of moderate-to-severe psoriasis with or...
Guardado en:
Autores principales: | Hannah Kaiser, Xing Wang, Amanda Kvist-Hansen, Martin Krakauer, Peter Michael Gørtz, Benjamin D. McCauley, Lone Skov, Christine Becker, Peter Riis Hansen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6f131e9fedf64742b1a91acddcc8ef0d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso R, et al.
Publicado: (2019) -
Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
por: Javier Donate-Correa, et al.
Publicado: (2021) -
Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries.
por: Ole Ahlehoff, et al.
Publicado: (2012) -
Psoriasis carries an increased risk of venous thromboembolism: a Danish nationwide cohort study.
por: Ole Ahlehoff, et al.
Publicado: (2011) -
Clinical significance of subclinical atherosclerosis in retinal vein occlusion
por: Minhyung Lyu, et al.
Publicado: (2021)